✦ LIBER ✦

COST-EFFECTIVENESS OF RIVAROXABAN COMPARED TO WARFARIN FOR STROKE PROPHYLAXIS IN ATRIAL FIBRILLATION

✍ Scribed by Soyon Lee; Moise Anglade; Robyn Pisacane; Dan Pham; Jeffrey Kluger; Craig Coleman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost–Effectiveness of Rivaroxaban Compar

✍ Soyon Lee; Moise W. Anglade; Dan Pham; Robyn Pisacane; Jeffrey Kluger; Craig I. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 786 KB

PCV57 Cost-Effectiveness of Rivaroxaban

✍ A.K. Kapur; I. Chatzitheofilou; L.K. Schang 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

TPDM2: COST-EFFECTIVENESS OF INCREASING

✍ DR Touchette; PJ Keys; E Racine; RM Massanari; J Andersen; J Stevenson 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB

COST-EFFECTIVENESS OF APIXABAN COMPARED

✍ Soyon Lee; Moise Anglade; Kelly Hagstrom; Joy Meng; Jeffrey Kluger; Craig Colema 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Cost-effectiveness of apixaban vs warfar

✍ Kamel, H.; Easton, J. D.; Johnston, S. C.; Kim, A. S. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 578 KB

PCV54 Cost-Effectiveness Analysis of Dab

✍ M.A. Ward; A.K. Biddle 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB